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| INTRODUCTION
Beyond pulmonary vein (PV) isolation, the two strategies that have historically prevailed for persistent atrial fibrillation (AF) ablation remain controversial. 1 The first strategy used lines of block aiming to partition the atria, as proposed with the Cox-maze. 2 A later strategy consisted of targeting the electrical signature of the mechanisms (bursting foci, meandering wavelets, etc.) maintaining the fibrillatory process. 3, 4 In randomized studies, both strategies have failed to decrease AF recurrences when compared with PV isolation alone. 5 In our experience, their combination into the "stepwise approach"
improved freedom from arrhythmic events, but at the cost of extensive ablation with impaired atrial physiology and recurrent tachycardias needing repeated procedures. 6, 7 These complex re-entries partly result from the difficulty to create durable transmural lesions, especially when using a linear ablation approach. High-density mapping of these arrhythmias has pointed out two additional findings. First, a patchy lesion set is highly proarrhythmogenic, favoring macro-re-entry through conduction slowing and providing pivots for localized re-entries. 8 Second, discrete anatomical structures such as the vein of Marshall (VOM) and the coronary sinus (CS) have epicardial muscular bundles that are more frequently involved in re-entry than previously expected. 9, 10 The present case series reports the preliminary results of a new strategy focusing on important anatomical targets individually recognized but not systematically combined, with the expectation of a higher single procedure success rate and limited impact on atrial physiology.
| METHODS
Patients with persistent AF were considered for ablation following guidelines criteria. 1 Written and oral consent was obtained in all. The ablation protocol was approved by our local ethics committee. The complete lesion set, based on three mandatory steps, was the procedural endpoint ( Figure 1 ).
| General principles
Technical details for intracardiac access have been previously described. Ethanol (100%) infusion was carried out in three separate 1-minute injections. Repeat angiograms were performed after each injection to confirm balloon stability. The endpoint was ethanol injection, for a total amount of 6 to 12 mL.
• CS and great cardiac vein ablation: targeting epicardial muscular bundles accompanying the CS. Using the sheath, ablation started at the great cardiac vein, which frequently shows myocardial coverage. 12 Ablation was pursued up to 1 cm after VOM ostium, respecting CS proximal portion to limit the risk of atrioventricular node-injury.
The endpoint was the elimination of all sharp near-field electrograms.
• Ridge and "saddle" ablation: targeting the Marshall bundles from an endocardial aspect. The "saddle" area (the crescent-shaped region between the high ridge, the left atrial appendage (LAA), the left superior PV and the roof) and the ridge are the insertion sites of the Marshall bundles. 13 Ethanol infusion most often has a significant impact on the ridge below the carina, but atrial signals frequently persist above this level, requiring additional RF applications. Ablation started at the lower part of the ridge displaying these signals and was pursued up to the "saddle." The endpoint was the elimination of all sharp near-field electrograms.
| Step 2: Wide antral PV isolation
This step aimed for PV isolation using wide antral circumferential ablation (WACA). Complete left PV encirclement was not systematically needed as step 1 participated in left antrum isolation. The endpoint was antral circumferential exit block. 
| Inducibility testing
In the absence of AF termination after the three steps, external direct current electrical cardioversion was performed to confirm the antral exit block at the PVs and bidirectional block along each line.
Once the lesion set achieved, burst pacing was delivered as follows:
(1) from LAA and proximal CS; (2) down to 200 ms (or to the local refractory period, if above); and (3) three times at each site.
Inducibility was defined as an arrhythmia lasting more than 5 minutes. A final voltage-map (low-voltage defined as < 0.5 mV)
was performed in sinus rhythm, during which interatrial delay (from P-wave onset to latest electrogram in the LA) was measured.
| Follow-up
All patients were discharged with a 1-month antiarrhythmic medication.
Follow-up was performed at 3 and 6 months, with a 12-lead ECG, a 24-hour Holter recording, and a trans-thoracic echocardiography. In 
| RESULTS
Clinical and procedural characteristics of the first 10 patients treated with this new approach are summarized in Tables 1 and 2 
| Preservation of atrial physiology
A strategy focusing on electrical substrate ablation bears the risk of neglecting the anatomical location of the targets and associated impact on atrial physiology. Injury of Bachmann's bundle can disrupt left atrial activation, sometimes leading to inadvertent LAA isolation. 18 Massive myocardial scarring increases the risk of the stiff left atrial syndrome. 19 Our experience with the stepwise approach shows that extensive lesions impair atrial conduction system and contractile function. 6, 20 Therefore, our new lesion set delivers radiofrequency to reasonably limited areas respecting atrial physiology. In particular, the mitral line is strategically placed posterior rather than anterior: the first location is close to the natural collision site observed in sinus rhythm, whereas the second location alters left atrial propagation and contraction by transecting Bachmann's bundle. 21 In the present case series, the interatrial delay is shorter than with our historical stepwise approach and the A-wave velocity at 3 months is similar to reference ranges in absence of ablation. 20, 22 Interestingly, the troponin-I level at day-1 does not exceed ranges observed after ablation. 
| Completion of feasible and reproducible steps
As the electrical signature of the mechanisms maintaining AF remains a matter of debate, the final lesion set of an electrical substrate ablation may vary from one institution to another. Conversely, a pure anatomical ablation such as the Cox-maze, which has demonstrated good long-term results, is based on reproducible steps. 2 Therefore, our new ablation strategy focuses on structures involved in the fibrillatory process and the recurrent tachycardias: the CS-VOM musculature, the PV and the anatomical isthmuses (mitral, roof, and cavotricuspid). Such anatomical targets provide clear, reproducible, but challenging steps as they require optimal lesion creation. However, attention paid on contact-force, catheter stability, power delivery, and interlesion distance has considerably facilitated PV isolation as well as cavotricuspid and roof lines block, which account for a substantial part of our new lesion set. [24] [25] [26] [27] The mitral line only, when placed posteriorly to avoid Bachmann's bundle injury, remains difficult to achieve despite these improvements: the main pitfall comes from the epicardial course of VOM bundles, protected against radiofrequency by fibro-fatty insulation. From this perspective, our preliminary results show that VOM ethanol infusion is feasible in a reasonably limited time and guarantees a high rate of mitral line block. Of interest, time spent on this maneuver is partly offset by a decrease of radiofrequency devoted to the left inferior PV and the endocardial aspect of the mitral isthmus. 28, 29 The originality of our new ablation strategy consists of combining previously identified targets in a judicious order.
| Prevention of recurrent tachycardias
In our experience, the remarkable per-procedural termination rate obtained with electrical substrate ablation has been counter-balanced by an "incoming tide" of complex tachycardias requiring repeated ablation procedures. 7 The recent advent of high-density mapping has helped us characterize their nature and identify their cause. Apart from exceptional focal activities, the vast majority of these tachycardias result from re-entrant mechanisms. 8 Macro-re-entries running through anatomical isthmuses (mitral, roof, and cavotricuspid) are predominant, and should be prevented by the completion of anatomical lines, as in the present strategy. Localized re-entries are probably promoted by ablation relatedscars, and may be reduced by avoiding patchy lesions. In our experience, the CS-VOM musculature is involved in more than 30% of cases in both types of re-entry. 10 The systematic elimination of these epicardial bundles might, therefore, prove very useful. Our institution has also recently shown that an anteroseptal conduction obstacle can favor a specific subset of macro-re-entry: the biatrial tachycardia. In this regards, prevention of recurrent tachycardias may be facilitated by the choice of a posterior rather than septal mitral line. vivo model has demonstrated that they can give rise to random circuits of re-entry, which may be crucial for the fibrillatory process. 33 By means of chemical and physical ablation, the first step of our new ablation strategy aims for the systematic elimination of this muscular continuum.
| Procedural endpoint: lesion set rather than AF termination
The same ex vivo model has shown that the elimination of the CS-VOM bundles prevents AF induction. 34 In line with this, our case series report a high rate of noninducibility despite a limited rate of termination. Such 
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discrepancy suggests that the mechanisms involved in AF perpetuation may not be decisive for AF priming. Of interest, minimally invasive surgical ablation has shown that a poor termination rate does not preclude good long-term results. 35 With the notion of AF priming, we hypothesize that anatomical re-entries randomly running through critical paths (CS-VOM bundles, PV, anatomical isthmuses, etc.) natively present in the atria may provide the conditions that subsequently promote AF perpetuation. In light of our encouraging short-term results, a systematic lesion set designed to close the critical paths of these anatomical re-entries might be an alternative to a tailored but extensive electrical substrate ablation aiming for AF termination.
| Limitations
Besides its noncomparative nature, the main limitations of our case series come from the small sample size and the short follow-up.
However, we believe that the preliminary results are promising and justify larger series with long-term follow-up.
| CONCLUSION
With the present case series, we report a new strategy for persistent AF ablation, exclusively guided by anatomical considerations. 
